A clinical formulation indicated for Eye Care. Application supports the reduction of intraocular pressure and aids in maintaining optimal ocular stability for eye wellness.
A combination eye drop developed to manage high intraocular pressure and designed to alleviate glaucoma symptoms to support eye health.
Mechanism of Action
Timolol reduces fluid production in the eye. Brimonidine both reduces fluid production and increases fluid drainage, providing a dual effect to lower pressure.
Route of Administration
Ophthalmic
Onset Time
1 hour
Duration
12 hours
Contraindications
Asthma, Severe COPD, Slow heart rate, Heart failure, Allergy to timolol or brimonidine
Information for Combigan is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
